DDR2 and ovarian carcinoma: We have previously shown that COL11A1 confers cisplatin resistance by engaging α1β1 integrin and Discoidin domain receptor 2 (DDR2) on ovarian cancer cells to activate c-Src-Akt-NFkB signaling to induce inhibitor of apoptosis proteins (IAPs)31.